Literature DB >> 29016353

Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.

Aleksandra Pyziak1, Agnieszka Zmyslowska1, Katarzyna Bobeff1, Beata Malachowska1, Wojciech Fendler1, Krystyna Wyka1, Anna Baranowska-Jazwiecka1, Malgorzata Szymanska1, Agnieszka Szadkowska1, Wojciech Mlynarski1.   

Abstract

BACKGROUND: The aim of the study was to compare the selected markers in children with and without partial clinical remission (CR) of newly diagnosed type 1 diabetes (T1D).
METHODS: The study group consisted of 186 patients (F/M; 87/99) at onset of T1D and 24 months of follow-up. Partial CR was defined as insulin requirement <0.5 IU/kg and glycated hemoglobin (HbA1c) <7%.
RESULTS: Partial CR was observed in 115/186 (61.83%) of patients. At diagnosis body mass index standard deviation (BMI SDS) was higher among remitters than in non-remitters (p=0.0051) and remitters were younger (p=0.0029). In the follow-up a higher triglyceride concentration in non-remitters compared to remitters (p=0.0455) and a lower high density lipoprotein (HDL) cholesterol level (p=0.0119) were noticed.
CONCLUSIONS: Younger age and higher BMI at diagnosis of T1D can predispose to partial CR in children. In patients with CR of T1D after 2 years of follow-up a lipid profile improvement is observed.

Entities:  

Keywords:  BMI; clinical remission; lipids; type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 29016353     DOI: 10.1515/jpem-2017-0100

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.

Authors:  Benjamin Udoka Nwosu
Journal:  Eur Med J Diabetes       Date:  2019-03-14

2.  Circulating Hematopoietic (HSC) and Very-Small Embryonic like (VSEL) Stem Cells in Newly Diagnosed Childhood Diabetes type 1 - Novel Parameters of Beta Cell Destruction/Regeneration Balance and Possible Prognostic Factors of Future Disease Course.

Authors:  Milena Jamiołkowska-Sztabkowska; Kamil Grubczak; Aleksandra Starosz; Anna Krętowska-Grunwald; Magdalena Krętowska; Zuzanna Parfienowicz; Marcin Moniuszko; Artur Bossowski; Barbara Głowińska-Olszewska
Journal:  Stem Cell Rev Rep       Date:  2021-09-12       Impact factor: 6.692

3.  Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.

Authors:  Laia Gomez-Muñoz; David Perna-Barrull; Josep M Caroz-Armayones; Marta Murillo; Silvia Rodriguez-Fernandez; Aina Valls; Federico Vazquez; Jacobo Perez; Raquel Corripio; Luis Castaño; Joan Bel; Marta Vives-Pi
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

4.  Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission.

Authors:  Tsz Wai Catherine Wong; Man Yee Shirley Wong; Wai Man Betty But
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.